Skip to content

Insider · CIK 0001729184

Fuping Chen

officer

Files at ACMR (ACM Research, Inc.). First filing Dec 4, 2025, latest Dec 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $4.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ACMR: ACM Research, Inc.

ACMROct 9, 2026 · close 71.37

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
ACMRsell 310b5-1
ACM Research, Inc.
$4.0M
120,000 shares
-120%+133% from low-25% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 2, 2025ACMR
ACM Research, Inc.
MOption exercise
Class A Common Stock10b5-1
+100,000$1.77$177k100,000Dec 4, 2025
Dec 2, 2025ACMR
ACM Research, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-100,000$33.20$3.3M0Dec 4, 2025
Dec 3, 2025ACMR
ACM Research, Inc.
MOption exercise
Class A Common Stock10b5-1
+20,000$1.77$35k20,000Dec 4, 2025
Dec 3, 2025ACMR
ACM Research, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-19,700$33.05$651k300Dec 4, 2025
Dec 3, 2025ACMR
ACM Research, Inc.
SOpen-market sale
Class A Common Stock10b5-1
-300$33.57$10k0Dec 4, 2025
Dec 2, 2025ACMR
ACM Research, Inc.
MOption exercise
Stock Optionderivative10b5-1
-100,000$0.00$041,165Dec 4, 2025
Dec 3, 2025ACMR
ACM Research, Inc.
MOption exercise
Stock Optionderivative10b5-1
-20,000$0.00$021,165Dec 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.